Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cisplatin plus radiotherapy versus cetuximab plus radiotherapy in locally advanced head and neck cancer
2012-001879-37Phase 3Terminated
- Sponsor
- Skåne University Hospital
- Start
- Dec 2012
- Modality
- Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in head and neck squamous cell carcinoma (HNSCC) comparing Cisplatin plus radiotherapy with Cetuximab plus radiotherapy (2 arms). Primary endpoint: Overall survival. Started Dec 2012; status: terminated.
02
Drugs
cetuximabcisplatin
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on 2012-001879-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001879-37.